Restricted Calorie Ketogenic Diet for the Treatment of Glioblastoma Multiforme

  title={Restricted Calorie Ketogenic Diet for the Treatment of Glioblastoma Multiforme},
  author={Joseph C. Maroon and Jeffrey W Bost and Austin Amos and Giulio Zuccoli},
  journal={Journal of Child Neurology},
  pages={1002 - 1008}
Glioblastoma multiforme is the most common malignant primary brain tumor in adults and generally considered to be universally fatal. Glioblastoma multiforme accounts for 12% to 15% of all intracranial neoplasms and affects 2 to 3 adults per every 100,000 in the United States annually. In children glioblastoma multiforme accounts for only approximately 7% to 9% of central nervous system tumors. The mean survival rate in adults after diagnosis ranges from 12 to 18 months with standard therapy and… 
The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature
Recent clinical findings have demonstrated that induced hypoglycemia and ketogenic diet are tolerable and can potentially be an adjuvant to standard treatments, such as surgery and chemoradiation.
Treatment of glioblastoma multiforme with “classic” 4:1 ketogenic diet total meal replacement
Treatment of GBM patients with 4:1 KD using total meal replacement program with standardized recipes was well tolerated and one patient with recurrent GBM and progression on bevacizumab experienced a remarkable symptom reversal, tumor shrinkage, and edema resolution.
Could Metabolic Therapy Become a Viable Alternative to the Standard of Care for Managing Glioblastoma
Studies in preclinical models show that calorie restricted ketogenic diets (KD-R), anti-glycolytic drugs, and hyperbaric oxygen therapy can reduce availability of glucose and glutamine in the tumor microenvironment while enhancing oxidative stress in tumor cells.
MR-Spectroscopy and Survival in Mice with High Grade Glioma Undergoing Unrestricted Ketogenic Diet
The accumulation of b HB in the tumor tissue in mice undergoing the KD, may suggest either elevated uptake/release of bHB by tumor cells, or the inability of tumor cells in this context to use it for mitochondrial metabolism.
Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.
Glioblastoma multiforme (GBM) is the most common primary brain tumour in adults. The standard therapy for GBM is maximal surgical resection followed by radiotherapy with concurrent and adjuvant
Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
The long-term survival of this patient, now at 80 months, could be due in part to a therapeutic metabolic synergy between KMT and the IDH1 mutation that simultaneously target the glycolysis and glutaminolysis pathways that are essential for GBM growth.
Treatment of glioma patients with ketogenic diets: report of two cases treated with an IRB-approved energy-restricted ketogenic diet protocol and review of the literature
KD is safe and without major side effects; ketosis can be induced using customary foods; treatment with KD may be effective in controlling the progression of some gliomas; and further studies are needed to determine factors that influence the effectiveness of KD.
Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model
The data show efficacy of combining an anti-angiogenic cyclophosphamide dosing regimen with dietary intervention in a preclinical NB model, which might open a new front in NB treatment.


The Restricted Ketogenic Diet : An Alternative Treatment Strategy for Glioblastoma Multiforme a report
Information is provided on how the restricted ketogenic diet (RKD) might serve as an effective alternative to the current standard of care for controlling growth and enhancing survival in patients with GBM.
Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report
This is the first report of confirmed GBM treated with standard therapy together with a restricted ketogenic diet, and as rapid regression of GBM is rare in older patients following incomplete surgical resection and standard therapy alone, the response observed in this case could result in part from the action of the calorie restrictedketogenic diet.
Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.
While this ketogenic diet does not replace conventional antineoplastic treatments, these preliminary results suggest a potential for clinical application which merits further research.
Canadian recommendations for the treatment of glioblastoma multiforme
Recommendation 1 Management of patients with glioblastoma multiforme (gbm) should be highly individualized and should take a multidisciplinary approach involving neuro-oncology, neurosurgery,
Targeting energy metabolism in brain cancer: review and hypothesis
A radically different approach to brain cancer management is proposed that combines metabolic control analysis with the evolutionarily conserved capacity of normal cells to survive extreme shifts in physiological environment.
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet
The results suggest that management of malignant astrocytoma with restricted ketogenic diets could be enhanced when combined with drugs that inhibit glycolysis.
Genetic alterations and signaling pathways in the evolution of gliomas
The current status of genetic alterations and signaling pathways operative in the evolution of astrocytic and oligodendroglial tumors is summarized.
Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial
Pilot data suggest that a ketogenic diet is suitable for even advanced cancer patients and has no severe side effects and might improve aspects of quality of life and blood parameters in some patients with advanced metastatic tumors.
Clinical Aspects of the Ketogenic Diet
This critical analysis of the ketogenic diet should provide the impetus for further clinical and basic research into the diet's application and mechanisms of action.